TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Lynch syndrome for the gynaecologist

Key Statistics

  • 1:278–440 — Population prevalence of Lynch syndrome
  • ~3% — Endometrial cancers caused by Lynch syndrome
  • ≤56.7% — Lifetime EC risk (MSH2, by age 70)

Don't-miss facts

  1. LS = autosomal dominant MMR gene defect (MLH1, MSH2, MSH6, PMS2, ±EpCAM); prevalence 1 in 278–440, ≤95% unaware

  2. Gene-specific EC risk by 70y: MLH1 42.7%, MSH2 56.7%, MSH6 46.2%, PMS2 26.4% – MSH6 EC risk high despite low CRC risk

  3. NICE: universal LS screening for all endometrial cancers where resources allow

  4. Tumour testing (IHC/MSI) needs no explicit consent; germline testing is definitive and always needs informed consent

  5. Risk-reducing hysterectomy+BSO timing: MLH1/MSH2 35y, MSH6 40y, PMS2 50y

  6. Pembrolizumab licensed for MSI-H/MMR-deficient tumours of any primary site

  7. PREMM5: >5% → refer genetics; >2.5% → tumour testing

  8. LS surveillance evidence weak; LS-EC 10-yr survival ≥90%; no proven OC surveillance benefit

Testing pathway at a glance

Tumour triage (IHC ± MSI ± MLH1 methylation) – no consent needed Germline NGS – definitive, always needs informed consent

Abbreviation Key

  • LS — Lynch syndrome
  • PGT — pre-implantation genetic testing
  • MMR — DNA mismatch repair
  • HFEA — Human Fertilisation and Embryology Authority
  • MLH1/MSH2/MSH6/PMS2 — mismatch repair genes
  • BSO — bilateral salpingo-oophorectomy
  • EpCAM — epithelial cell adhesion molecule
  • EC/OC — endometrial cancer / ovarian cancer
  • IHC — immunohistochemistry
  • NICE — National Institute for Health and Care Excellence
  • MSI — microsatellite instability
  • PD-1/PD-L1 — programmed cell death protein 1 / its ligand
  • MSI-H/L/MSS — MSI-high / MSI-low / microsatellite stable
  • FDA — US Food and Drug Administration
  • VUS — variant of unknown significance
  • UKFOCS — United Kingdom Familial Ovarian Cancer Screening Study
  • NGS — next-generation sequencing
  • CI — confidence interval

Source: Ryan N et al. Lynch syndrome for the gynaecologist. The Obstetrician & Gynaecologist 2021;23:9–20. doi:10.1111/tog.12706

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free